mrjСовременная ревматологияModern Rheumatology Journal1996-70122310-158XIMA-PRESS, LLC10.14412/1996-7012-2010-608mrj-293Research ArticleСтатьиArticlesАнтималярийные препараты в терапии системной красной волчанки: прошлое, настоящее, будущееANTIMALARIAL DRUGS IN THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS: PAST, PRESENT, FUTUREЛисицынаТ. А.LisitsynaTatyana Andreyevnatalisitsyna@rambler.ru <mailto:talisitsyna@rambler.ru>КошелеваН. М.KoshelevaN M-20102006201042№2 (2010)8188Copyright © Лисицына Т.А., Кошелева Н.М., 20102010Лисицына Т.А., Кошелева Н.М.Lisitsyna T.A., Kosheleva N.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://mrj.ima-press.net/mrj/article/view/293

The data available in the literature on experience in using antimalarial drugs in the treatment of systemic lupus erythematosus are summarized. A major emphasis is placed on therapy with hydroxychlorochine (plaquenil) versus chlorine. Possible mechanisms of action of the drug and its effect on the course of the disease itself and concomitant abnormalities are described. Data on the toxicity of the drug and its safe use in pregnancy and lactation are also discussed

The data available in the literature on experience in using antimalarial drugs in the treatment of systemic lupus erythematosus are summarized. A major emphasis is placed on therapy with hydroxychlorochine (plaquenil) versus chlorine. Possible mechanisms of action of the drug and its effect on the course of the disease itself and concomitant abnormalities are described. Data on the toxicity of the drug and its safe use in pregnancy and lactation are also discussed

гидроксихлорохинсистемная красная волчанкабезопасностьбеременностьhydroxychlorochinesystemic lupus erythematosussafetypregnancyReferences

The authors declare that there are no conflicts of interest present.